1. Home
  2. BBSI vs GYRE Comparison

BBSI vs GYRE Comparison

Compare BBSI & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

N/A

Current Price

$31.61

Market Cap

818.9M

ML Signal

N/A

Logo Gyre Therapeutics Inc.

GYRE

Gyre Therapeutics Inc.

N/A

Current Price

$7.04

Market Cap

750.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBSI
GYRE
Founded
1965
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
818.9M
750.7M
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
BBSI
GYRE
Price
$31.61
$7.04
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
★ $40.75
$18.67
AVG Volume (30 Days)
★ 190.0K
141.6K
Earning Date
11-04-2026
11-06-2026
Dividend Yield
★ 0.99%
N/A
EPS Growth
★ 5.05
N/A
EPS
★ N/A
N/A
Revenue
★ $920,432,000.00
$275,000.00
Revenue This Year
$3.97
N/A
Revenue Next Year
$5.34
$27.49
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 9.50
N/A
52 Week Low
$25.33
$5.44
52 Week High
$43.53
$9.42

Technical Indicators

Market Signals
Indicator
BBSI
GYRE
Relative Strength Index (RSI) 45.19 49.93
Support Level $29.99 $6.55
Resistance Level $31.99 $7.34
Average True Range (ATR) 0.96 0.34
MACD 0.13 -0.06
Stochastic Oscillator 49.05 30.15

Price Performance

Historical Comparison
BBSI
GYRE

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Share on Social Networks: